Li AM, Hucks GE, Dinofia AM, et al. Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia. ASH Annual Meeting and Exposition 2018, abstract 556.
Nieuwe CAR T-celtherapiefaciliteit op Leiden Bio Science Park
apr 2021 | Leukemie, Lymfoom